Clinical Trial Update: A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness of oregovomab plus chemotherapy in advanced ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Neoplasms

Drugs mentioned

• Oregovomab (oregovomab)

Snippet

Sponsor: Quest PharmaTech Inc. | Conditions: Ovarian Neoplasms | Phase 2 | Status: COMPLETED